---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004490"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-01-31T23:59:59+00:00"
generated_at: "2026-05-27T04:44:58.851733+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions plans multilingual upgrade for drug screening system, aims to reach 4B users

## Summary
- Multilingual upgrade will support languages across Americas, Europe, Asia Pacific, and Middle East, accessible to over 4 billion speakers worldwide.
- Supports planned 2025 entry into US market following FDA 510(k) submission in December 2024.
- Company has existing presence in 19 countries; targets safety-critical industries like construction, mining, and transport.
- Drug screening market projected to reach approximately $8 billion globally by 2030.

## SEC filing metadata
- accession: 0001493152-25-004490
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-01-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/0001493152-25-004490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225004490/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004490
- JSON: https://secwatch.observer/filing/0001493152-25-004490.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004490.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.